Clinical trial · Interventional
Improving Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial
The Effectiveness of the Quality Program Pac-IficO to Improve Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of the study is to evaluate the efficacy of the Pac-IFicO programme in improving the quality of pain management in hospitalised cancer patients. This is a before-after cluster phase II study performed in medicine, oncology and respiratory disease hospital wards. The Pac-IFicO programme is a complex interventions with multiple components. The primary end-point of the study is the proportion of cancer patients with severe pain.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| the Pac-IFicO programme | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- The Pac-IFicO programme
- description
- The Pac-IFicO programme is a complex interventions aimed at improving the quality of pain managementi in hospitalized patients.
- interventionNames
- Other: the Pac-IFicO programme
Primary outcomes (1)
- measure
- percentage of hospitalized cancer patients with average severe pain (score 7-10) within the latest 24 hours
- timeFrame
- up to 28±1 days after Pac-IficO completion.
- description
- All eligible patients will be assessed in the month before (the before sample) and in the month after the implementation of the intervention (the after sample). For both samples the outcomes are composite measures from the five assessments in the month before and from five assessments in the month after. Each outcome results from the sum of patients with severe pain in the five assessments (the numerator) divided the total number of assessed patients in the five assessments (the denominator) x 100.
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria WARD LEVEL 1. consent from the head of the ward to participate to the study; 2. ward classified as oncology, medicine, respiratory disease ward according to the regional classification of hospitals; 3. number of beds: ≥20 ; 4. number of ordinary admissions with primary or secondary diagnosis of tumour (ICD-IX 140-239) \>180 per year; 5. yearly average stay in hospital between 4 and 19 days; 6. punctual prevalence of patients with primary or secondary diagnosis of tumour (ICD-IX 140-239) ≥ 8 patients. STAFF LEVEL 1. affiliation to the ward; 2. informed consent to participate to the study. PATIENT LEVEL 1. ordinarily admitted in the ward for at least 24 hours; 2. age ≥ 18 years 3. able to fill in the questionnaire according the profession judgment; 4. informed consent to participate to the study. Exclusion criteria WARD LEVEL 1\. the ward had received or is receiving quality improvement programme of staff education for improve pain control. PATIENT LEVEL 1\. patient already assessed in one of the previous assessments.
References
Publications (1)
- DERIVEDRipamonti CI, Prandi C, Costantini M, Perfetti E, Pellegrini F, Visentin M, Garrino L, De Luca A, Pessi MA, Peruselli C. The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients: a before-after cluster phase II trial. BMC Palliat Care. 2014 Mar 29;13(1):15. doi: 10.1186/1472-684X-13-15. PMID 24678911